Castle Biosciences ‘ Melanoma Gene Expression Profile Test To Be Subject Of Presentation At American Society of Clinical Oncology Annual Meeting /PRNewswire/ — Castle Biosciences Inc. announced today that abstracts reporting additional clinical validation data for two of its molecular tests — one focused on melanoma and the other on esophageal … (more)
Source: www.topix.com Via newsmixx: home News